Australia becomes the first nation to address PTSD by allowing MDMA and psilocybin

Per Nature

Australia is now the first country ever to allow PTSD treatment to include MDMA and psilocybin drugs. However, some clinicians are sharing concerns about how drug regulations for these substances might not be enough.

The Therapeutic Goods Administration (TGA), the country's drug regulator, approved the decision, saying it followed a nearly three-year process. TGA's former head, John Skerritt, gave a statement regarding the decision.

Skerritt: “We were quite deliberate in not saying, ‘Here’s the clinical protocol.’ We’re not the regulators of clinical practice... It is quite likely that other groups, whether they be clinical professional groups or others, will release guidance around it.”

On July 1, Australia would be a step ahead of the US, Canada, and Israel, which allowed people to use drugs in clinical trials or on compassionate grounds. Swinburne University of Technology psychiatrist Susan Rosselle gave a statement regarding the treatment.

Rosselle: “It’s not for everybody. We need to work out who these people are that are going to have bad experiences, and not recommend it,”

In February, it was reported that Canada's British Columbia decriminalized owning 2.5 grams of illegal drugs for adults 18 and older. These include opioids, crack, meth, and MDMA.

In October, Biden pardoned prior federal offenses of weed possession.

See flow at unusualwhales.com/flow.

Other News:

Resources:

Nature

tastytrade logo+
Get the best broker for options trading and earn Unusual Whales discounted! in cash with an eligible account deposit at tastytrade. Get an Unusual Whales bonus when you deposit $2000. Offer expires 3/31/25. Certain restrictions, terms and conditions apply.
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.